Ocular Therapeutix
OCUL
#5266
Rank
$1.67 B
Marketcap
$7.60
Share price
1.26%
Change (1 day)
-36.15%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -$0.31 Billion USD

According to Ocular Therapeutix's latest financial reports the company's current earnings are $52.05 Million USD. In 2025 the company made an earning of -$0.27 Billion USD a decrease over its 2024 earnings that were of -$0.2 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$0.31 Billion13.35%
2025 -$0.27 Billion37.43%
2024 -$0.2 Billion139.68%
2023 -$80.74 Million13.65%
2022 -$71.04 Million984.05%
2021 -$6.56 Million-95.79%
2020 -$0.16 Billion80.19%
2019 -$86.38 Million44.01%
2018 -$59.98 Million-5.38%
2017 -$63.39 Million41.79%
2016 -$44.71 Million12.47%
2015 -$39.75 Million38.75%
2014 -$28.65 Million115.12%
2013 -$13.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-$11.21 Million-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-$5.13 Million-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-$0.17 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
$0.16 B-153.18%๐Ÿ‡บ๐Ÿ‡ธ USA